Czy istnieje różnica w jakości życia i występowaniu objawów psychiatrycznych u chorych na akromegalię i inne choroby przewlekłe?
Dorota Szczęśniak(Wroclaw Medical University), Marek Bolanowski(University Hospital and Clinics), Anna Bolanowska(Wroclaw Medical University), Joanna Rymaszewska(Wrocław University of Science and Technology), Julian Maciaszek(Wroclaw Medical University), Łukasz Matusiak(Wrocław University of Science and Technology), Aleksandra Jawiarczyk-Przybyłowska(Wroclaw Medical University), Małgorzata Siemińska(Wroclaw Medical University)
Cited by 19
Related Papers
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
|Journal of the European Academy of Dermatology and Venereology|2015|1.1k
Hidradenitis suppurativa
|Nature Reviews Disease Primers|2020|567
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity
|British Journal of Dermatology|2017|467
Diagnostic delay in hidradenitis suppurativa is a global problem
|British Journal of Dermatology|2015|392
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
|The Journal of Clinical Endocrinology & Metabolism|2019|363